Tumor-derived exosomes (TEXs) and immune cell-derived exosomes (IEXs) have been demonstrated to activate immune responses by transferring antigens to antigen presenting cells (APCs), which results in the activation of CD4+ T cells and CD8+ T cells, thereby enhancing the anti-tumor responses and leading to the inhibition of tumor progression [17]. This evidence concerns the gene CD4 and neoplasm.